fingolimod hydrochloride has been researched along with Nervous System Disorders in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 6 (75.00) | 24.3611 |
| 2020's | 2 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bascuñana, P; Brackhan, M; Möhle, L; Pahnke, J | 1 |
| Cohen, JA; McGinley, MP | 1 |
| Antel, J; Hohlfeld, R | 1 |
| Goodin, D | 1 |
| Willoughby, E | 1 |
| Hasegawa, Y; Lekic, T; Manaenko, A; Ostrowski, R; Rolland, WB; Tang, J; Zhang, JH | 1 |
| Graves, D; Vernino, S | 1 |
| Altay, O; Hartman, R; Hasegawa, Y; Krafft, PR; Lekic, T; Manaenko, A; Ostrowski, R; Rolland, WB; Tang, J; Zhang, JH | 1 |
3 review(s) available for fingolimod hydrochloride and Nervous System Disorders
| Article | Year |
|---|---|
Fingolimod as a Treatment in Neurologic Disorders Beyond Multiple Sclerosis.
Topics: Alzheimer Disease; Animals; Anti-Inflammatory Agents, Non-Steroidal; Disease Models, Animal; Drug Evaluation, Preclinical; Epilepsy; Fingolimod Hydrochloride; Humans; Lymphocytes; Mice; Multiple Sclerosis; Nervous System Diseases; Neuroprotective Agents; Rats; Sphingosine 1 Phosphate Receptor Modulators | 2020 |
Sphingosine 1-phosphate receptor modulators in multiple sclerosis and other conditions.
Topics: Animals; Azetidines; Benzyl Compounds; Clinical Trials as Topic; Fingolimod Hydrochloride; Humans; Immune System Diseases; Indans; Multiple Sclerosis; Nervous System Diseases; Oxadiazoles; Signal Transduction; Sphingosine 1 Phosphate Receptor Modulators; Sphingosine-1-Phosphate Receptors; Thiazoles | 2021 |
Immunotherapies in neurologic disorders.
Topics: Adjuvants, Immunologic; Adrenal Cortex Hormones; Antibodies, Monoclonal, Humanized; Antibodies, Monoclonal, Murine-Derived; Azathioprine; Cyclophosphamide; Cyclosporine; Fingolimod Hydrochloride; Glatiramer Acetate; Humans; Immunoglobulins, Intravenous; Immunologic Factors; Immunosuppressive Agents; Interferon beta-1a; Interferon beta-1b; Interferon-beta; Mitoxantrone; Mycophenolic Acid; Natalizumab; Nervous System Diseases; Peptides; Plasma Exchange; Propylene Glycols; Rituximab; Sphingosine; Tacrolimus | 2012 |
5 other study(ies) available for fingolimod hydrochloride and Nervous System Disorders
| Article | Year |
|---|---|
Modulation of sphingosine 1-phosphate signaling in neurologic disease.
Topics: Fingolimod Hydrochloride; Humans; Immunosuppressive Agents; Lysophospholipids; Nervous System Diseases; Propylene Glycols; Signal Transduction; Sphingosine | 2011 |
Multiple Sclerosis: The Big Questions- The MS Forum Workshop.
Topics: Canada; Cladribine; Fingolimod Hydrochloride; Humans; Multiple Sclerosis; Nervous System Diseases; Neurology; Societies, Medical | 2011 |
American academy of neurology annual meeting.
Topics: Academies and Institutes; Administration, Oral; Canada; Cladribine; Fingolimod Hydrochloride; Humans; Multiple Sclerosis; Nervous System Diseases; Neurology | 2011 |
FTY720 is neuroprotective and improves functional outcomes after intracerebral hemorrhage in mice.
Topics: Analysis of Variance; Animals; Brain Edema; Cerebral Hemorrhage; Collagenases; Disease Models, Animal; Fingolimod Hydrochloride; Functional Laterality; Immunosuppressive Agents; Mice; Nervous System Diseases; Neurologic Examination; Propylene Glycols; Psychomotor Performance; Sphingosine; Time Factors | 2011 |
Fingolimod reduces cerebral lymphocyte infiltration in experimental models of rodent intracerebral hemorrhage.
Topics: Analysis of Variance; Animals; Basal Ganglia; Behavior, Animal; Blood Transfusion, Autologous; Brain Edema; CD3 Complex; Cell Count; Cerebral Cortex; Cerebral Hemorrhage; Collagenases; Disease Models, Animal; Fingolimod Hydrochloride; Forelimb; Functional Laterality; Immunosuppressive Agents; Intercellular Adhesion Molecule-1; Interferon-gamma; Interleukin-17; Leukocytes; Lymphocytes; Male; Maze Learning; Mice; Nervous System Diseases; Propylene Glycols; Psychomotor Disorders; Rats; Rats, Sprague-Dawley; Space Perception; Sphingosine; Time Factors | 2013 |